Skip to content
OpenCapital
Get started

Wave Life Sciences WVE Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$11.2M-15.6%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$1.7M+67.0%
ALN
Alnylam PharmaceuticalsALNY
$45.66M-0.8%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$14.78M+11.9%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$5.03M-1.5%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$406K-31.1%

Other financials

Income statement

See full
Revenue$38.2M+317%
Operating income-$31.3M+37.2%
Net income-$26.1M+44.4%
EPS (diluted)-$0.13+55.2%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total debt$15.7M-33.4%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.14B+13.0%
Enterprise value$615.92M-22.3%
P/S15.1×-12.2×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%—
Debt / equity0×-0.1×
Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wave Life Sciences's operating lease liabilities (current)?
Wave Life Sciences (WVE) reported operating lease liabilities (current) of $8.33M in Q1 2026.
How has Wave Life Sciences's operating lease liabilities (current) changed year-over-year?
Wave Life Sciences's operating lease liabilities (current) increased by 5.6% year-over-year, from $7.88M to $8.33M.
What is the long-term trend for Wave Life Sciences's operating lease liabilities (current)?
Over 5 years (2020 to 2025), Wave Life Sciences's operating lease liabilities (current) has grown at a 17.6% compound annual growth rate (CAGR), from $3.71M to $8.36M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.